For research use only. Not for therapeutic Use.
Warangalone(Cat No.:R056963)is a bioactive compound with potential therapeutic properties, derived from natural sources. It exhibits significant anticancer and anti-inflammatory activity by modulating key signaling pathways, including those involved in apoptosis and cell cycle regulation. Warangalone has shown promise in preclinical studies as an inhibitor of tumor cell proliferation and an inducer of apoptosis, making it a potential candidate for cancer treatment. Additionally, its ability to reduce inflammation suggests potential applications in inflammatory diseases. Ongoing research is focused on optimizing its pharmacological profile for therapeutic use in oncology and immunology.
Catalog Number | R056963 |
CAS Number | 4449-55-2 |
Molecular Formula | C25H24O5 |
Purity | ≥95% |
Target | TGF-beta/Smad |
Storage | Store at -20°C |
IUPAC Name | 5-hydroxy-7-(4-hydroxyphenyl)-2,2-dimethyl-10-(3-methylbut-2-enyl)pyrano[3,2-g]chromen-6-one |
InChI | InChI=1S/C25H24O5/c1-14(2)5-10-18-23-17(11-12-25(3,4)30-23)21(27)20-22(28)19(13-29-24(18)20)15-6-8-16(26)9-7-15/h5-9,11-13,26-27H,10H2,1-4H3 |
InChIKey | HGHOPAZIUPORIN-UHFFFAOYSA-N |
SMILES | CC(=CCC1=C2C(=C(C3=C1OC=C(C3=O)C4=CC=C(C=C4)O)O)C=CC(O2)(C)C)C |